GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (NSE:SUPRIYA) » Definitions » Operating Cash Flow per Share

Supriya Lifescience (NSE:SUPRIYA) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience Operating Cash Flow per Share?

Supriya Lifescience's operating cash flow per share for the three months ended in Mar. 2025 was ₹0.00. Supriya Lifescience's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Supriya Lifescience was 45.30% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 50.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Supriya Lifescience's Operating Cash Flow per Share or its related term are showing as below:

NSE:SUPRIYA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -44.2   Med: -26.85   Max: 50
Current: 50

During the past 7 years, Supriya Lifescience's highest 3-Year average Operating Cash Flow per Share Growth Rate was 50.00% per year. The lowest was -44.20% per year. And the median was -26.85% per year.

NSE:SUPRIYA's 3-Year OCF Growth Rate is ranked better than
87.55% of 1221 companies
in the Biotechnology industry
Industry Median: 9.3 vs NSE:SUPRIYA: 50.00

Supriya Lifescience Operating Cash Flow per Share Historical Data

The historical data trend for Supriya Lifescience's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience Operating Cash Flow per Share Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Operating Cash Flow per Share
Get a 7-Day Free Trial 29.71 6.06 7.90 14.08 20.46

Supriya Lifescience Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Supriya Lifescience's Operating Cash Flow per Share

For the Biotechnology subindustry, Supriya Lifescience's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supriya Lifescience's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Supriya Lifescience's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Supriya Lifescience's Price-to-Operating-Cash-Flow falls into.


;
;

Supriya Lifescience Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Supriya Lifescience's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2025 is calculated as

Operating Cash Flow per Share (A: Mar. 2025 )=Cash Flow from Operations (A: Mar. 2025 )/Shares Outstanding (Diluted Average) (A: Mar. 2025 )
=1646.75/80.496
=20.46

Supriya Lifescience's Operating Cash Flow per Share for the quarter that ended in Mar. 2025 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )=Cash Flow from Operations (Q: Mar. 2025 )/Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
=0/80.198
=0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Supriya Lifescience Business Description

Traded in Other Exchanges
Address
Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience Headlines

No Headlines